Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EDIT

Editas Medicine (EDIT)

Editas Medicine Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EDIT
DateTimeSourceHeadlineSymbolCompany
10/05/202420:00GlobeNewswire Inc.Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual MeetingNASDAQ:EDITEditas Medicine Inc
09/05/202406:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EDITEditas Medicine Inc
08/05/202422:29IH Market NewsU.S. Futures Slightly Dip Amid Corporate Earnings and Quiet Economic Calendar, Oil Prices FallNASDAQ:EDITEditas Medicine Inc
08/05/202421:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EDITEditas Medicine Inc
08/05/202421:00GlobeNewswire Inc.Editas Medicine Announces First Quarter 2024 Results and Business UpdatesNASDAQ:EDITEditas Medicine Inc
02/05/202421:00GlobeNewswire Inc.Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor EventsNASDAQ:EDITEditas Medicine Inc
01/05/202422:00GlobeNewswire Inc.Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell CollaborationNASDAQ:EDITEditas Medicine Inc
23/04/202406:31GlobeNewswire Inc.Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual MeetingNASDAQ:EDITEditas Medicine Inc
06/03/202412:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
06/03/202412:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
06/03/202412:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
06/03/202411:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
05/03/202409:58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EDITEditas Medicine Inc
29/02/202409:13Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:EDITEditas Medicine Inc
29/02/202408:39Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:EDITEditas Medicine Inc
28/02/202423:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EDITEditas Medicine Inc
28/02/202423:00GlobeNewswire Inc.Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business UpdatesNASDAQ:EDITEditas Medicine Inc
21/02/202423:00GlobeNewswire Inc.Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor EventsNASDAQ:EDITEditas Medicine Inc
15/02/202400:40Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:EDITEditas Medicine Inc
01/02/202401:00GlobeNewswire Inc.Editas Medicine to Participate in Upcoming Investor ConferencesNASDAQ:EDITEditas Medicine Inc
09/01/202400:15GlobeNewswire Inc.Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare ConferenceNASDAQ:EDITEditas Medicine Inc
03/01/202423:00GlobeNewswire Inc.Editas Medicine to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:EDITEditas Medicine Inc
14/12/202304:48Dow Jones NewsEditas Medicine Strikes License Deal With Vertex Pharmaceuticals -- UpdateNASDAQ:EDITEditas Medicine Inc
14/12/202301:49Dow Jones NewsEditas Medicine Strikes License Deal With Vertex PharmaceuticalsNASDAQ:EDITEditas Medicine Inc
14/12/202301:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EDITEditas Medicine Inc
14/12/202301:00GlobeNewswire Inc.Editas Medicine and Vertex Pharmaceuticals Enter into Non-exclusive License Agreement for Cas9NASDAQ:EDITEditas Medicine Inc
12/12/202308:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EDITEditas Medicine Inc
12/12/202304:00GlobeNewswire Inc.Editas Medicine Announces New EDIT-301 Safety and Efficacy Data in 17 Patients, Presented Today at the American Society of Hematology (ASH) Annual Meeting and in a Company-sponsored WebinarNASDAQ:EDITEditas Medicine Inc
08/12/202308:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
23/11/202308:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EDITEditas Medicine Inc
 Showing the most relevant articles for your search:NASDAQ:EDIT

Your Recent History

Delayed Upgrade Clock